Conference 2021

The 27th Annual Conference was held online on 11th and 12th November 2021

Delivered in bite size chunks on 11th and 12th November delegates participated during the live broadcast and invaluable Q&A sessions, or simply watched on-demand when they could.   


HSIB’s approach to investigations Helen Jones, National Investigator, Healthcare Safety Investigation Branch (HSIB)

Standardising IV infusions Dr Sara Arenas- Lopez, Consultant Pharmacist Paediatric Critical Care, Evelina London Children’s Hospital, Guy’s & St Thomas‘ NHS Foundation Trust and Adam Sutherland, Clinical Pharmacist, PICU, Royal Manchester Children’s Hospital and Clinical Lecturer, University of Manchester

STEP database – Accelerating the development of medicines for children through open access excipient database Smita Salunke, EuPFi Chief Scientific Officer, UCL

SNAP Dr Mark Anderson, Consultant Paediatrician and Clinical Director, Great North Children’s Hospital

NPPG in the past 12 months – and AGM Nigel Gooding, Consultant Pharmacist – Neonates & Paediatrics, Cambridge University Hospitals NHS Foundation Trust & Chair, NPPG

Leadership in pharmacy – inclusivity Elsy Gomez Campos, FRPharmS , Diversity and Inclusion lead at Kent Community Health NHS Foundation Trust, President and Founder of the UK Black Pharmacist Association (UKBPA) and President of PDABAME Network

Metabolic bone disease in neonates Dr Chris Foster, Consultant in Neonates, Leeds Teaching Hospitals NHS Foundation Trust

Getting started in research Dr Andy Fox PhD, Consultant Pharmacist Medicines Safety, Deputy Chief Pharmacist – Risk, Research, Education, University Hospitals Southampton NHS Foundation Trust

What’s new in children’s medicines? Steve Tomlin, Chief Pharmacist, Great Ormond Street Hospital & Professional Lead, NPPG

Short papers in the spotlight – links take you to the online version on Archives of Disease in Childhood

Using Kotter’s change model to reduce paediatric prescribing errors Ashifa Trivedi, Divisional Lead Pharmacist Women & Children / Co-Chair NMP Lead, The Hillingdon Hospitals NHS Foundation Trust

NPPG & RCPCH position statement: using standardised concentrations of unlicensed liquid medicines in children. How well has it been adopted nationally? Andrew Wignell, Advanced Pharmacist Practitioner, Paediatric Critical Care, Nottingham University Hospitals NHS Trust

Understanding lived experiences: a novel undergraduate paediatric work-based learning placement Nicola Vasey, Lead Pharmacist Great North Children’s Hospital & Lead Pharmacist Women’s Services

Implementation of smart-pumps and standard concentration infusions across a paediatric hospital group – a training and evaluation model Moninne Howlett, Chief Pharmacy Information Officer, Children’s Health Ireland

Parent-led administration of medicine on the neonatal unit Sarah Murray, Lead Clinical Pharmacist – Medicine, Craigavon Area Hospital, Southern Health and Social Care Trust

Community pharmacy services available for children in England Steve Tomlin, Chief Pharmacist, Great Ormond Street Hospital

What should you anticipate & prepare for during a pandemic – conversion of a paediatric intensive care unit to an adult intensive care unit – a pharmacy perspective Joanne Crook, Consultant Pharmacist Paediatrics, King’s College Hospital

Pharmacist-led centralised prescribing service for paediatric growth hormone in South Wales Ross Burrows, Lead Pharmacist Paediatric Endocrinology, Noah’s Ark Children’s Hospital for Wales

Parent co-designed drug information for parents and guardians taking neonates home – survey of healthcare professionals and parents/carers – an interim analysis Dr Louise Bracken, Senior Research Pharmacist and Co-Director Paediatric Medicines Research Unit, Alder Hey Children’s NHS Foundation Trust

Where title is linked click to view the abstract / poster (members only). Where poster number is linked this takes you to the online version on Archives of Disease in Childhood (access free)

P01 Reducing Interruptions during administration of medicines to children Andrea Gill, Alder Hey Children’s Hospital NHS Foundation Trust

P02 Use of intrathecal fluorescein to identify cerebrospinal fluid (CSF) rhinorrhea in paediatrics: a case report and literature review Komal Vaddy, King’s College Hospital

P03 Paracetamol dosing in hospitalised children – a national survey Andrea Gill, Alder Hey Children’s Hospital NHS Foundation Trust

P04 Variability in concentration of oral liquid medicines prescribed for children in England – an analysis Andrew Wignell, Nottingham Children’s Hospital

P05 A project to rationalise the prescribing of unlicensed specials for children in a UK clinical commissioning group Sheatha Abumehdi, Evelina London Children’s Hospital

P06 Development of a hydroxycarbamide telephone clinic for children with sickle cell disease Alexandra Hollwey, Leeds Teaching Hospital NHS Trust

P07 Hormonal contraceptives: safe for use in adolescent girls? Mohammed Abou Daya, Barts Health NHS Trust

P08 Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings Conor Sin, Aston University

P09 Management of aggressive systemic mastocytosis in a 4kg infant Abbey Forster, Royal Manchester Children’s Hospital

P10 App for paediatric inflammatory bowel disease (PIBD) patients – a successEmma Williams, Cambridge University Hospitals NHS Foundation Trust

P11 Using novel technology to improve communication to and between pharmacy staff  Paul Turner, Bristol Royal Hospital for Children

P12 Do paediatric dosing sets for intravenous (IV) PiperacillinPiperacillin/Tazobactam and oral morphine make it more likely to get ‘the dose right first time’ in an electronic prescribing system? Amy Hill, Liverpool John Moores/Alder Hey

P13 Vitamin D preparations: what’s in the bottle? Mandy Wan, Evelina London Children’s Hospital

P14 Identification of prescribing errors in a paediatric intensive care unit (PICU): an audit Rachel Rowley, Liverpool John Moores University

P15 Feasibility of the introduction of aseptically prepared dose banded antimicrobials in a paediatric hospital Laily Sadozai, Evelina London Children Hospital

P17 Dose Range Checking (DRC) in paediatric electronic prescribing; an effective tool

in reducing prescribing errors? Elizabeth Kane, Liverpool John Moores University

P18 Role of the pharmacy team in paediatric palliative carSian Gaze, Evelina London Children’s Hospital

P19 A mixed method study to evaluate the medicines optimisation pathway following virtual outpatient clinics Victoria Tsang, Royal Brompton Hospital

P20 Child presenting with paroxysmal atrio-ventricular heart block, a multi-disciplinary team approach Elaine Liston, Royal Hospital for Children, Glasgow

P21 Introduction of standardised parenteral nutrition for use in preterm neonates in a neonatal intensive care unit at a large tertiary hospital Sarah Whiteley, Leeds Teaching Hospitals NHS Trust

P22 Unlicensed medicines use in neonates: do we know what we’re giving? Thomas Wyllie, Cardiff & Vale University Health Board

P23 Off-label Use of Interleukin-6 inhibitors in paediatrics: a systematic review Asia N Rashed, Institute of Pharmaceutical Science, King’s College London

P24 Primary pharmaceutical care and young people: Exploring young people perspectives Mohammed Almunef, University of Birmingham

P25 Assessing compliance with oxygen prescribing in paediatrics Hafsah Badshah, Alder Hey Children’s Hospital

P26 Could the formulation and/or method of administration of oral nadolol have a clinically significant impact on the dose delivered to the patient Anita Aindow, Alder Hey Children’s Hospital

P28 Paediatric COVID toes and the recommended care management Christina Leung, Chelsea and Westminster Hospital

P29 Medicine prescribing across primary, secondary and tertiary care interfaces in paediatrics: a retrospective cohort study Caprice Birring, King’s College London

P30 Improving the documentation of paediatric height/length for inpatients Ailbhe Keevey, University Hospitals Bristol and Weston NHS Foundation Trust

P31 Optimisation of smart-pump drug library functionality – supporting national standardisation Moninne Howlett, Children’s Health Ireland

P32 Children’s hospital discharge collaborative: getting home in time for tea Catherine Bell, Leeds Children’s Hospital

P33 Modified point prevalence study of antifungal use in paediatrics Kara Tedford, Children’s Health Ireland (CHI), at Crumlin

P34 Medicines optimisation for infants and children attending a children’s cardiology ward for day case diagnostic cardiac catheter procedures Stephen Morris, Leeds Teaching Hospitals NHS Trust

P35 An evaluation of clopidogrel use in a children’s cardiology centre Stephen Morris, Leeds Teaching Hospitals NHS Trust

P36 Medications given via enteral feeding tubes to paediatric inpatientAndrea Gill, Alder Hey Children’s Hospital NHS Foundation Trust

P37 Administering medicines safely at home: using an evidence-based approach to help a family with complex health needs Stephen Morris, Leeds Teaching Hospitals NHS Trust

P38 An audit of excipients of one manufacturer’s unlicensed liquid preparations in a tertiary paediatric hospital Mary Worrall, Children’s Health Ireland (CHI) at Crumlin

P40 Implementation of standard Parenteral Nutrition (PN) in a large tertiary neonatal service during COVID-19 pandemic – the considerations, the challenges and the lessons learnt Rebecca Hinton, Manchester University Foundation Trust

P41 Evaluating patient/carer satisfaction with medicines information provision within paediatric neurology outpatients Suzannah Hibberd, Southampton Children’s Hospital

P42 Evaluating the impact of triple combination modulators on medication adherence in cystic fibrosis Sharon Sutton, Children’s Health Ireland (CHI) at Crumlin

The conference on Twitter

Click here to see how the conference unfolded on Twitter